Jessica Tassan
Stock Analyst at Piper Sandler
(0.99)
# 2,732
Out of 4,412 analysts
42
Total ratings
29.41%
Success rate
-15.68%
Average return
Main Sectors:
Top Industries:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Overweight | $566 → $571 | $495.35 | +15.27% | 4 | Apr 17, 2024 | |
| CVS CVS Health | Maintains: Overweight | $93 → $94 | $67.18 | +39.92% | 3 | Mar 15, 2024 | |
| ALHC Alignment Healthcare | Downgrades: Neutral | $12 → $6 | $5.21 | +15.16% | 2 | Mar 6, 2024 | |
| HCAT Health Catalyst | Reiterates: Overweight | $17 → $15 | $6.03 | +148.76% | 6 | Feb 23, 2024 | |
| TDOC Teladoc Health | Maintains: Overweight | $30 → $25 | $13.01 | +92.16% | 3 | Feb 21, 2024 | |
| ACCD Accolade | Maintains: Overweight | $12 → $15 | $7.89 | +90.11% | 4 | Jan 9, 2024 | |
| DOCS Doximity | Maintains: Neutral | $21 → $23 | $23.82 | -3.44% | 3 | Nov 10, 2023 | |
| CMAX CareMax | Downgrades: Neutral | $60 | $3.12 | +1,823.08% | 3 | Nov 10, 2023 | |
| PHR Phreesia | Maintains: Overweight | $43 → $40 | $20.61 | +94.08% | 3 | Sep 12, 2023 | |
| PINC Premier | Downgrades: Neutral | $44 → $25 | $20.96 | +19.27% | 2 | Aug 23, 2023 | |
| OMCL Omnicell | Downgrades: Neutral | $66 → $70 | $27.86 | +151.26% | 4 | Aug 2, 2023 | |
| AMWL American Well | Downgrades: Neutral | $5 → $3.5 | $0.53 | +562.88% | 2 | Feb 27, 2023 | |
| MDRX Veradigm | Downgrades: Neutral | $17 → $19 | $7.96 | +132.41% | 1 | Feb 1, 2023 | |
| EVH Evolent Health | Maintains: Overweight | $40 → $33 | $27.65 | +19.35% | 2 | Nov 4, 2022 |
UnitedHealth Group
Apr 17, 2024
Maintains: Overweight
Price Target: $566 → $571
Current: $495.35
Upside: +15.27%
CVS Health
Mar 15, 2024
Maintains: Overweight
Price Target: $93 → $94
Current: $67.18
Upside: +39.92%
Alignment Healthcare
Mar 6, 2024
Downgrades: Neutral
Price Target: $12 → $6
Current: $5.21
Upside: +15.16%
Health Catalyst
Feb 23, 2024
Reiterates: Overweight
Price Target: $17 → $15
Current: $6.03
Upside: +148.76%
Teladoc Health
Feb 21, 2024
Maintains: Overweight
Price Target: $30 → $25
Current: $13.01
Upside: +92.16%
Accolade
Jan 9, 2024
Maintains: Overweight
Price Target: $12 → $15
Current: $7.89
Upside: +90.11%
Doximity
Nov 10, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $23.82
Upside: -3.44%
CareMax
Nov 10, 2023
Downgrades: Neutral
Price Target: $60
Current: $3.12
Upside: +1,823.08%
Phreesia
Sep 12, 2023
Maintains: Overweight
Price Target: $43 → $40
Current: $20.61
Upside: +94.08%
Premier
Aug 23, 2023
Downgrades: Neutral
Price Target: $44 → $25
Current: $20.96
Upside: +19.27%
Omnicell
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $27.86
Upside: +151.26%
American Well
Feb 27, 2023
Downgrades: Neutral
Price Target: $5 → $3.5
Current: $0.53
Upside: +562.88%
Veradigm
Feb 1, 2023
Downgrades: Neutral
Price Target: $17 → $19
Current: $7.96
Upside: +132.41%
Evolent Health
Nov 4, 2022
Maintains: Overweight
Price Target: $40 → $33
Current: $27.65
Upside: +19.35%